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Abstract
Energy metabolism supports both inhibitory and excitatory
neurotransmission processes. This study investigated the
speciﬁc contribution of astrocytic metabolism to c-aminobutyric
acid (GABA) synthesis and inhibitory GABAergic neurotrans-
mission that remained to be ilucidated in vivo. Therefore, we
measured 13C incorporation into brain metabolites by dynamic
13C nuclear magnetic resonance spectroscopy at 14.1 T in
rats under a-chloralose anaesthesia during infusion of
[1,6-13C]glucose. The enhanced sensitivity at 14.1 T allowed
to quantify incorporation of 13C into the three aliphatic carbons
of GABA non-invasively. Metabolic ﬂuxes were determined
with a mathematical model of brain metabolism comprising
glial, glutamatergic and GABAergic compartments. GABA
synthesis rate was 0.11  0.01 lmol/g/min. GABA-glutamine
cycle was 0.053  0.003 lmol/g/min and accounted for
22  1% of total neurotransmitter cycling between neurons
and glia. Cerebral glucose oxidation was 0.47  0.02 lmol/g/min,
of which 35  1% and 7  1% was diverted to the glutama-
tergic and GABAergic tricarboxylic acid cycles, respectively.
The remaining fraction of glucose oxidation was in glia, where
12  1% of the TCA cycle ﬂux was dedicated to oxidation of
GABA. 16  2% of glutamine synthesis was provided to
GABAergic neurons. We conclude that substantial metabolic
activity occurs in GABAergic neurons and that glial metabo-
lism supports both glutamatergic and GABAergic neurons in
the living rat brain.
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metabolism.
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The vast majority of synapses in the central nervous system
use either glutamate or c-aminobutyric acid (GABA) to
mediate excitatory or inhibitory neurotransmission. Although
glutamatergic synapses outnumber GABAergic synapses and
the energetic requirements of excitatory neurons are consid-
ered higher than those of inhibitory neurons, a substantial
amount of glucose, the main substrate for cerebral energy
metabolism, has been suggested to be oxidized in inhibitory
GABAergic neurons (e.g. Patel et al. 2005; Calvetti and
Somersalo 2012; Howarth et al. 2012).
Nuclear magnetic resonance (NMR) spectroscopy has been
used to probe metabolic pathways in vivo upon infusion of
speciﬁc 13C-enriched substrates (Gruetter 2002). However,
GABA metabolism in vivo remains difﬁcult to study because
of its low concentration. Although several attempts were
made to detect 13C turnover curves of GABA, the dynamic
measurement of GABA enrichment was restricted to only
one or two carbons (Pfeuffer et al. 1999; Yang et al. 2005;
van Eijsden et al. 2010). Therefore, studies of brain metab-
olism mostly focused on glutamatergic function, as glutamate
is present in much higher concentrations. Determination of
the activity of GABAergic metabolic pathways is important
since GABA metabolism has been implicated in neurological
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disorders (reviewed in Choi and Shen 2012; Waagepetersen
et al. 1999): several psychiatric disorders were found to be
associated with modiﬁcation of inhibitory GABAergic
function, GABA metabolism and/or GABA levels; in
epilepsy, inhibition of GABA-transaminase (GABA-T, EC
2.6.1.19) or GABA transporters increases synaptic GABA
availability, which correlates with reduced glucose consump-
tion and improved seizure control.
GABA metabolism occurs in the GABA shunt (e.g. Choi
and Shen 2012). Brieﬂy, GABA is synthesized in the cytosol
from glutamate by glutamate decarboxylase (GAD, EC
4.1.1.15) and is catabolized in mitochondria, starting with
GABA conversion to succinic-semialdehyde (SSA) in mito-
chondria by GABA-T, with simultaneous amination of
2-oxoglutarate to glutamate, and then SSA catabolism to
succinate by SSA dehydrogenase (SSADH, EC 1.2.1.24), for
dual use in the tricarboxylic acid (TCA) cycle, and as
electron donor of the mitochondrial electron transport chain.
After synaptic release, GABA is believed to be mostly
cleared by neurons as GABA transporters are less abundant
in glial than neuronal membranes (Conti et al. 2004).
Nevertheless, uptake of GABA by astrocytes and further
metabolism through the GABA shunt, as well as glutamine
provision to GABAergic neurons by the GABA-glutamine
cycle, have been reported (Schousboe and Waagepetersen
2003, 2007; Bak et al. 2006). In previous 13C NMR
spectroscopy studies designed to quantify metabolic ﬂuxes
of GABA metabolism in the brain in vivo, astrocytic ﬂuxes
were either constrained to those in neurons or determined in
parallel experiments using 13C-enriched acetate that is
principally oxidized in glia (e.g. Patel et al. 2005; van
Eijsden et al. 2010). Therefore, the effective contribution of
astrocytic metabolism to GABAergic neurotransmission
remains to be addressed in vivo. The aim of this study was
to determine compartmentalized metabolic ﬂuxes in
GABAergic neurons and connecting astrocytes using the
resonances of all three aliphatic carbons of GABA at 14.1 T
in the living rat brain.
Materials and methods
Animals
All experimental procedures involving animals were approved by
the local ethics committee (EXPANIM-SCAV, Switzerland). Male
Sprague–Dawley rats (267  25 g, n = 8, purchased to Charles
River Laboratoires, L’Arbresle, France) were prepared as previously
detailed in Duarte et al. (2009). Brieﬂy, animals were mechanically
ventilated with a mixture of 30% O2 in air using pressure-driven
ventilator (MRI-1, CWE incorporated, Ardmore, PA, USA), and
catheters were placed into a femoral artery for collection of blood
samples and into a femoral vein for infusion of saline solutions
containing a-chloralose (Acros Organics, Geel, Belgium) or
[1,6-13C]glucose (Sigma-Aldrich, Basel, Switzerland). Light anaes-
thesia was achieved by administration of a-chloralose (bolus of
80 mg/kg and continuous infusion of 28 mg/kg/h). Arterial blood
pressure, heart rate and respiratory rate were continuously monitored
with an animal monitoring system (SA Instruments, Stony Brook,
NY, USA). Blood samples were collected every 20–30 min to
measure gases, pH, lactate and glucose. Arterial pH and pressures of
O2 and CO2 were measured using a blood gas analyser (AVL
Compact 3; Diamond Diagnostics, Holliston, MA, USA) and were
maintained within the normal physiological range by adjusting
respiratory rate and volume. Body temperature was maintained
between 37.0 and 37.5°C. Plasma glucose and lactate concentrations
were quantiﬁed with the glucose and lactate oxidase methods,
respectively, using two multi-assay analysers (GW7 Micro-Stat;
Analox Instruments, London, UK). The [1,6-13C]glucose infusion
procedure was previously described in Duarte et al. (2011) and
allowed to achieve a sustained plasma fractional enrichment (FE) of
70%, which was conﬁrmed by NMR spectroscopy of collected
plasma samples.
NMR spectroscopy
All in vivo NMR experiments were carried out in a DirectDrive
spectrometer (Agilent Technologies, Palo Alto, CA, USA) inter-
faced to a 26-cm horizontal bore 14.1 T magnet (Magnex Scientiﬁc,
Abingdon, UK), using a homebuilt coil consisting of a 1H
quadrature surface coil and a 13C linearly polarized surface coil
(Duarte et al. 2011). Animals were immobilized in a home-built
holder with a bite bar and two ear inserts to minimize potential
motion. The rat brain was positioned in the isocenter of the magnet
and fast-spin-echo images with repetition time of 4 s, echo time of
52 ms and echo train length of 8 allowed to identify anatomical
landmarks, which were used to place the volume of interest (VOI) of
320 lL in the brain. After FAST(EST)MAP shimming (Gruetter
1993; Gruetter and Tkac 2000), localized 1H NMR spectra were
acquired using STEAM with echo time of 2.8 ms, mixing time of
20 ms and repetition time of 4 s (Tkac et al. 2003; Mlynarik et al.
2006). 13C NMR spectra were acquired using semi-adiabatic
distortionless enhancement by polarization transfer (DEPT) com-
bined with 3D-ISIS 1H localization (Henry et al. 2003a).
Analysis of 1H and 13C NMR spectra was carried out using
LCModel (Stephen Provencher Inc., Oakville, ON, Canada) as
described by Mlynarik et al. (2006) and Henry et al. (2003b),
respectively. The scaling of dynamically measured 13C concentra-
tions was based on the FE determined in vitro in 13C NMR
spectra from perchloric acid extracts of the brain prepared at the
end of each experiment (detailed in Duarte et al. 2011). High-
resolution in vitro NMR spectroscopy was performed as described
in Duarte et al. (2007) using a 14.1 T DRX-600 spectrometer
equipped with a 5 mm cryoprobe (Bruker BioSpin SA, Fallenden,
Switzerland).
In general, total concentration of brain metabolites was deter-
mined by 1H NMR spectroscopy. Since glutamine levels from 1H
NMR spectra in vivo were lower than 13C-enriched glutamine in 13C
NMR spectra, total glutamine was calculated with the relation
between FE and the 13C content at steady state. FE is deﬁned as
FE ¼ ½13C½12C þ ½13C, which can be written as follows:
FE ½
12C þ ½13C
½13C ¼ 1, where [
13C] and [12C] + [13C] represent the
concentration of 13C label and the total concentration in a given
carbon, respectively. For glutamate and glutamine C3, one can
consider that
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FEGlnC3
½GlnC3 ½Gln ¼
FEGluC3
½GluC3 ½Glu
Assuming that the probability of 13C enrichment in C3 through
metabolism in the TCA cycle(s) is the same for molecules with or
without labelling in C4, FEC3 = C4D34/(C4S + C4D34) for both
glutamate (Glu) and glutamine (Gln), where C4D34 and C4S are,
respectively, the doublet and singlet in the resonance of C4 from
either glutamine or glutamate (e.g. Malloy et al. 1987; Gruetter
et al. 1994; Mason et al. 1995). Because C5 does not become
labelled upon infusion of [1,6-13C]glucose, the total C4 signal
corresponds to C4S + C4D34. Thus, the equation above can be
rewritten using 13C measured signals at steady state:
½Gln ¼ GlnC3GlnC4D34
GlnC4

GluC4D34
GluC4
GluC3
½Glu
Determination of metabolic fluxes and statistical analysis
Kinetic modelling of [1,6-13C]glucose metabolism in glutamatergic,
GABAergic and glial compartments was performed by extension of
the mathematical model of compartmentalized cerebral metabolism
previously described (Duarte et al. 2011). Figure 1 depicts the
metabolic pools and ﬂuxes deﬁned in the three-compartment model,
which is detailed in Appendix. Variations to this model were tested
and are subject of discussion (see below). In particular, the inclusion
of a glutamine pool exchangeable through Vex
g leads to a major ﬁt
improvement. Mathematical models were adjusted to the eleven 13C
enrichment curves of glutamate, glutamine and GABA C2, C3 and
C4, and of aspartate C2 and C3, using the Levenberg–Marquardt
algorithm for non-linear regression, coupled to a Runge-Kutta
method for non-stiff systems to obtain numerical solutions of the
ordinary differential equations that deﬁne the model (detailed in the
Appendix). Signiﬁcance of the ﬁtted parameters (ﬂuxes) was
inferred from t-statistics. F-statistics was used for relative assess-
ment of ﬁt quality. Because accuracy in ﬂux estimation is inversely
proportional to the noise level of experimental data (Shestov et al.
2007), 13C enrichment curves were averaged from all rats rather than
ﬁtting individual time courses. Then, reliability of determined ﬂuxes
was evaluated by Monte-Carlo analysis, in which Gaussian noise
with the same variance of ﬁt residuals was added to the best ﬁt and
initial conditions were randomly generated within conﬁdence interval
of the obtained value. Typically, 500 simulated data sets were created
for each individual analysis. The estimated metabolic ﬂuxes are
shown as mean  SD, being the SD resulting from ﬁtting a Gamma
function to the probability distribution obtained with theMonte-Carlo
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Fig. 1 Three-compartment model of brain metabolism. CMRglc is the
total cerebral metabolic rate of glucose. Pyruvate originated from
glucose consumption is in fast equilibrium with lactate that is
exchanged between neurons and glia and is diluted with extra-cerebral
lactate through Vout/Vin. VPDH
glu accounts for the total TCA cycle ﬂux in
glutamatergic neurons, VPDH
GABA + Vshunt
GABA is the total GABAergic
TCA cycle, Vg + VPC + Vshunt
g is the total glial TCA cycle, VPC is the
rate through pyruvate carboxylase. In the glial compartment, the
dilution of label at the level of acetyl-CoA (AcCoA) by glial-speciﬁc
substrates is accounted by Vdil. TCA cycle intermediates oxaloacetate
(OAA) and 2-oxoglutarate (OG) exchange with amino acids through
the exchange ﬂux VX. The glutamate-glutamine and GABA-glutamine
cycles are VNT
glu and VNT
GABA, respectively, and glutamine synthetase
rate is VGS. The GABA synthesis rate catalysed by glutamate
decarboxylase (VGAD) was restricted to GABAergic neurons. Vshunt
g
and Vshunt
GABA represent the oxidation of GABA in the glial and
GABAergic compartments, respectively. Finally, efﬂux of labelling from
the metabolic system occurs through the rate of glial glutamine loss
Vefﬂux. An additional glutamine pool in exchange via Vex
g was tested as
described in the text. The superscripts g, glu and GABA distinguish
metabolic pools or ﬂuxes in the glial, glutamatergic and GABAergic
compartments, respectively.
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simulations. All numerical procedures were performed using Matlab
(The MathWorks, Natick, MA, USA). Data are presented as
mean  SD of eight experiments, unless otherwise stated.
Results
Upon infusion of [1,6-13C]glucose, the FE of plasma glucose
was 0.71  0.02 after 5 min and over the whole period of
13C NMR spectra acquisition. When measuring the incorpo-
ration of 13C from [1,6-13C]glucose into amino acids in the
living rat brain using 13C NMR spectroscopy at 14.1 T
(volume of interest is shown in Fig. 2a), 20 carbon
resonances from 10 metabolites were detected between 15
and 65 ppm (Fig. 2b), including three GABA peaks that were
clearly detectable with 20 min of temporal resolution
(Fig. 2c). The analysis of 13C NMR spectra with LCModel
allowed to simultaneously quantify not only the three GABA
resonances but also their isotopomers (Fig. 3). The multiplets
in carbons of GABA arising from the presence of adjacent 13C
resonances were observed in the 13C NMR spectra in vivo
(Fig. 3a) as well as in vitro in brain PCA extracts (Fig. 3b).
Cramér-Rao lower bounds (CRLB) for GABA C2, C4 and C3
were below 30% from 54, 72 and 126 min after the beginning
of [1,6-13C]glucose infusion, respectively (Fig. 3c).
1H NMR spectroscopy was used to determine the total
concentration of brain metabolites that become enriched by
13C (Table 1). Brain metabolite levels were found to agree
with prior literature reports (Tkac et al. 2003; Duarte et al.
2011). However, total brain levels of glutamine measured by
1HNMR spectroscopy in vivowere found to be below those of
13C-enriched glutamine measured by 13C NMR spectroscopy.
Therefore, total glutamine was estimated at 5.3  0.4 lmol/g
using the relation between FE and the 13C signals observed at
steady-state (Table 1, discussed below).
When ﬁtting the mathematical model to the 13C time
courses of glutamate, glutamine, aspartate and GABA,
generally an excellent ﬁt was observed (Fig. 4), which
resulted in the metabolic ﬂuxes in Table 2. The curves
generated by the initial model were not a complete
representation of the data measured in vivo, which is
particularly clear for glutamine C4 (Fig. 4). The goodness-
of-ﬁt was improved by the inclusion of an additional
exchangeable glutamine pool in the glial compartment
(R2 = 0.976 and f = 1960, vs. R2 = 0.972 and f = 1680), as
indicated by the ﬁt residuals, that is, the mean residuals with
and without this glutamine pool were0.0034  0.0244 and
0.0042  0.0268 (dimension of FE) and the residual sum of
squares was 0.328 versus 0.395, respectively (Fig. 4b). The
exchange ﬂux Vex
g was found to be 0.060  0.008 lmol/g/
min and signiﬁcantly different from zero (t = 284). The other
metabolic ﬂuxes in the model were not substantially affected
by the inclusion of this additional glutamine pool (Table 2).
Thus, metabolic ﬂuxes are hereafter presented and discussed
for the model that includes Vex
g.
Total glucose oxidation, that is, cerebral metabolic rate for
glucose consumption (CMRglc(ox)), was 0.47  0.02 lmol/g/
min. Since glucose consumption was ﬁxed at 0.52 lmol/g/
min, as determined previously (see Appendix), net release of
lactate (Vout) was 0.11  0.03 lmol/g/min. About half of
glucose oxidation was found to occur through pyruvate
dehydrogenase in the glial compartment (47  3%), and a
considerable fraction because of pyruvate carboxylation: VPC
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Fig. 2 13C NMR spectra acquired in vivo at 14.1 T from the rat brain
upon infusion of [1,6-13C]glucose. In (a) is represented the volume of
interest (VOI) of 5 9 898 mm3 in the rat brain. Brain images are
0.8 mm of thickness and spaced by 1.6 mm. The sphere in the top is
the [13C]formic acid reference used for calibration of radiofrequency
pulses. (b) Shows a representative spectrum acquired for 1 h starting
after 5 h of [1,6-13C]glucose infusion, with identiﬁcation of visible
resonances (expansion from 15 to 65 ppm; Gaussian apodization with
gf = 0.08, gfs = 0.02). (c) Shows the time course of spectra with 20-
min time resolution acquired during 6 h starting at the onset of [1,6-13C]
glucose infusion. The top spectrum is the sum of the three last scans,
that is, acquired for 1 h (Lorentzian-Gaussian apodization was
employed with lb = 5, gf = 0.08, gfs = 0.02). Resonance assignment:
Ala, alanine; Lac, lactate; NAA, N-acetylaspartate; GABA, c-amino-
butirate; Gln, glutamine; Glu, glutamate, GSH, glutathione; Asp,
aspartate; Ser, serine; Glc, glucose.
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was 10  1% of CMRglc(ox) and 21  1% of VTCAg. In
glutamatergic and GABAergic neurons, the fraction of total
glucose oxidation was 35  1% and 7  1%, respectively.
VNT
GABA was 22  1% of total neurotransmitter cycling
between neurons and astrocytes. In GABAergic neurons,
VGAD was 0.11  0.01 lmol/g/min and VNTGABA was
0.053  0.003 lmol/g/min, which was set to be equal to
the GABAergic glutaminase ﬂux. Thus, glial glutamine
contributed to 48  5% of GABA synthesis. Glial VTCA
and VGS account for GABA recycling through the glial GABA
shunt, which was 12  1% of VTCAg and resulted in 16  2%
of glutamine synthesis (VGS) to be shuttled to GABAergic
neurons for GABA production. In total, the rate of glucose
oxidation supporting GABAergic activity was 13  1%
(VTCA
GABA + Vshunt
g). The rate of label exchange between
cytosolic amino acids and their mitochondrial counterparts,
namely mediated by the malate-aspartate shuttle, were on the
order of the TCA cycle rate in each compartment.
Discussion
This study reports for the ﬁrst time the in vivo measurement
of the 13C enrichment in all three aliphatic carbons of GABA
in the rat brain, which contributed to elucidate multiple
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Fig. 3 (a) Depicts a typical ﬁt obtained with LCModel for an in vivo 13C
NMR spectrum acquired for 2 h after 4 h of [1,6-13C]glucose infusion.
Expansions in the top of (a) show the ﬁtting of individual isotopomers in
GABA C2, C3 and C4. These were also observed in the high-
resolution spectrum acquired from brain extracts after [1,6-13C]glucose
infusion for 6 h (b). High-resolution 13C NMR spectra in vitro were
acquired at 600 MHz, pH 7.0 and 12°C to allow separation of NAA C3
and GABA C4 resonances. (c) Shows 13C signal and associated
Cramer-Rao lower bound (CRLB) for GABA resonances. Signal
intensity is given in arbitrary units (a.u.) and was not corrected for
relative DEPT enhancement or distance from the transmit/observe
frequency. Data are mean  SEM of eight rats.
Table 1 Total cerebral concentration of metabolites observable in 13C
NMR spectra in vivo upon infusion of [1,6-13C]glucose, as determined
by 1H NMR spectroscopy prior to substrate infusion. Concentrations
are shown as mean  SEM of eight rats
Concentration (lmol/g)
Glutamate 8.6  0.4
Glutamine 2.7  0.1; a5.3  0.4
Aspartate 2.2  0.3
GABA 1.3  0.1
GSH 0.91  0.09
NAA 8.8  0.4
Glucose 1.4  0.4
Lactate 0.71  0.05
Alanine 0.46  0.07
aglutamine concentration determined through FE of glutamate and
glutamine C3 in 13C NMR spectra and total glutamate content.
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aspects of metabolic compartmentation of GABA metabo-
lism in vivo. GABA C4 but not C3 and C2 receives labelling
from pyruvate through pyruvate carboxylation and thus it
allowed to determine the contribution of glial metabolism to
GABA synthesis, in addition to metabolic ﬂuxes in
GABAergic neurons (depicted in Fig. 1). In particular, we
found that a considerable fraction of glucose was oxidized in
the GABAergic compartment and connecting glial cells to
fulﬁl the energetic requirements of GABAergic neurotrans-
mission (13  1%), and that glial glutamine accounts for an
important fraction of GABA synthesis (48  5%).
Detection of 13C enrichment in GABA in vivo has been
mostly accomplished using indirect detection of signals from
13C-coupled protons. The ﬁrst turnover curve of 13C enriched
GABA in vivo was reported by Pfeuffer et al. (1999), who
measured GABA C3 in the rat brain during infusion of
[1-13C]glucose. Later, other GABA turnover curves were
determined in vivo (e.g. Yang et al. 2005; van Eijsden et al.
2010). Although the indirect detection of 13C-coupled
protons has a high signal-to-noise ratio of protons, the low
chemical shift dispersion, even at 14.1 T (Xin et al. 2010),
results in substantial signal overlap. In contrast, the wide
chemical shift dispersion of direct 13C NMR spectra at high
ﬁeld allowed to quantify all three aliphatic GABA reso-
nances. This study demonstrates the simultaneous quantiﬁ-
cation of the three aliphatic carbons of GABA with an
average precision (CRLB) of 0.17 lmol/g (Fig. 3c) at a
temporal resolution comparable to that of studies using 1H-
observed-13C-edited spectroscopy methods (Pfeuffer et al.
1999; Yang et al. 2005; van Eijsden et al. 2010), a
possibility that was not hitherto accessible at lower magnetic
ﬁelds, especially for GABA C4, which partially overlaps
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Fig. 4 Fractional enrichment in carbons of glutamate, glutamine,
GABA and aspartate, and curves of the best ﬁt of the three-
compartment model (a). Data points are the mean of 8 rats, shaded
area represents respective SD, blue and red lines depict the best ﬁt to
the data of the three-compartment model with one or two glial
glutamine pools. Fit residuals of the models (b) with one (blue
symbols) or two (red symbols) glial glutamine pools indicate ﬁt
improvement by addition of the glutamine pool with low 1H NMR
visibility. The lines on the right show the distribution of the residuals for
each model.
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with the C3 of N-acetylaspartate (aspartyl moiety) (e.g. Choi
and Gruetter 2003). The ability to quantify all GABA signals
was ascribed to increased spectral resolution and high signal
achieved at 14.1 T with surface coil signal detection,
quantiﬁcation by LCModel and use of [1,6-13C]glucose
infusion that leads to a nearly twofold increase in the
fractional enrichment of observed metabolites, compared to
the use of [1-13C]glucose as substrate.
Cerebral metabolism of GABA and GABA-glutamine cycle
When comparing the ﬂuxes obtained with the present three-
compartment model (Fig. 1) to those obtained by ﬁtting the
previously published two-compartment model of brain
energy metabolism (Duarte et al. 2011), we noted that most
metabolic ﬂuxes were not substantially different (Fig. 5a).
Glucose oxidation was higher (0.47  0.02 vs.
0.38  0.02 lmol/g/min) and the net release of lactate (Vout)
was 62  11% lower than when using the two-compartment
model (both with CMRglc = 0.52 lmol/g/min). Thus, a
substantial fraction of glucose utilization in the rat brain is
involved in maintaining GABAergic function, rather than
released as lactate. This indicates that the inclusion of a
GABAergic compartment leads to a more complete account
for total glucose metabolism.
A small but signiﬁcant fraction of glucose was directly
utilized in GABAergic neurons (7  1% of total oxidation),
as found by Patel et al. (2005) with quantiﬁcation of 13C
GABA in brain extracts, suggesting that excitation plays an
energetically dominant role. Anatomical and physiological
data support the concept that inhibitory neurotransmission
overall requires less energy compared to glutamatergic
activity. Indeed, glutamatergic synapses outnumber
GABAergic synapses by ﬁvefold, with less than 30% of
cortical neurons being inhibitory GABAergic interneurons
(DeFelipe and Fari~nas 1992; Sahara et al. 2012), and the
energetic requirements of excitatory neurons have been
suggested to be nearly three times those of inhibitory neurons
(Howarth et al. 2012). Although it has been suggested that
the recycling of GABA may not be coupled to glucose
utilization in astrocytes, even though astrocytes respond to
GABA by increasing intracellular sodium content (Chatton
et al. 2003) according to the stechiometry of co-transport
with two Na+ and one Cl (Gadea and Lopez-Colomé 2001),
this does not preclude that activity of GABAergic nerve
terminals per se does not involve energy consumption in
neighbouring astrocytes. When providing simultaneously
[U-13C]glucose and [2-13C]acetate to superfused hippocam-
pal slices we previously found lower but signiﬁcant contri-
bution of acetate metabolized in glia to the multiplets of
GABA, compared to those of glutamate, which further
increases upon stimulation (Duarte et al. 2007).
It should be noted that the inclusion of GABAergic activity
in the model lead to a substantial increment in the glial VTCA to
47  3% of total glucose oxidation (Fig. 5a), as part of it is
required for GABA oxidation through the GABA shunt
(12  1% of VTCAg), which resulted in synthesis of glutamine
Table 2 Cerebral metabolic ﬂuxes determined with the three-compartment model of [1,6-13C]glucose metabolism. Estimated ﬂuxes are shown in
lmol/g/min with associated SD and t-value in parenthesis
One glial glutamine pool
R2 = 0.972, f = 1680
With additional glutamine pool
R2 = 0.976, f = 1960
Determined VPDH
Glu (= VTCA
Glu) 0.36  0.01 (995) 0.33  0.01 (931)
VPDH
GABA 0.024  0.005 (174) 0.017  0.005 (141)
Vg 0.26  0.02 (408) 0.29  0.03 (409)
VPC (= Vefﬂux) 0.076  0.004 (704) 0.092  0.005 (714)
Vdil
g 1.1  0.1 (189) 0.76  0.07 (297)
VNT
Glu 0.16  0.01 (381) 0.18  0.01 (471)
VNT
GABA (= Vshunt
g) 0.044  0.002 (504) 0.053  0.003 (602)
VGAD
GABA 0.098  0.003 (886) 0.11  0.01 (970)
Vx
Glu 0.41  0.02 (568) 0.39  0.02 (625)
Vx
GABA 0.0067  0.0038 (63.5) 0.0068  0.0034 (77.5)
Vx
g 0.010  0.011 (28.4) 0.018  0.018 (35.1)
Vex
g 0.060  0.008 (284)
Calculated CMRglc(ox) 0.44  0.02 0.47  0.02
Vout 0.16  0.03 0.11  0.03
VTCA
GABA 0.077  0.007 0.070  0.007
VTCA
g 0.38  0.02 0.44  0.03
Vshunt
GABA 0.054  0.004 0.053  0.005
VGS 0.28  0.01 0.33  0.01
VNT
total 0.20  0.01 0.24  0.01
Vx
g + VPC + Vshunt
g (OG?Glu) 0.13  0.01 0.16  0.02
Vx
GABA + Vshunt
GABA (OG?Glu) 0.060  0.006 0.060  0.006
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to be shuttled to GABAergic neurons for GABA production
(16  2% of VGS). In this study, when accounting for this
fraction of glial TCA cycle that is involved in supporting
GABA recycling, the total glucose oxidation attributed to
GABAergic function was 13  1% of total CMRglc(ox).
Astrocytes lack the enzymatic machinery for GABA
synthesis and, therefore, virtually all glial GABA originates
from neuronal release (Schousboe and Waagepetersen 2003).
In fact, we tested the presence of VGAD in the glial
compartment and this ﬂux was consistently not signiﬁcantly
different from zero (not shown). Although not being able to
synthesize GABA, astrocytes play an important role in
GABA metabolism (reviewed in Schousboe et al. 1992;
Choi and Shen 2012). In the present model, the ﬂux through
GAD was set to be equal to the sum of the glial and neuronal
GABA shunts (thus respecting steady-state mass balance)
that are associated with the respective GABA-T activities
initiating GABA catabolism in mitochondria. Our results for
Vshunt
GABA and Vshunt
g (Table 2) suggest that nearly half of
GABA produced in GABAergic neurons is further oxidized
in astrocytes through the glial GABA shunt and that half of
GABA synthesis relies on glutamine provided by astrocytes,
which is consistent with studies in cultured cortical neurons
(Westergaard et al. 1995). This does not mean, however, that
equal amounts of synaptically released GABA are taken up
by astrocytes and neurons, while glutamate transporters in
astrocytes largely exceed those in neurons, GABA trans-
porters are mostly concentrated in membranes of GABAergic
neurons (Conti et al. 2004), suggesting preferential uptake of
glutamate by astrocytes and of GABA by neurons (e.g.
Schousboe and Waagepetersen 2003, 2007; Bak et al. 2006).
Thus, it may be suggested that a substantial amount of
GABA released into the synapse must be taken up by same
nerve terminal and directly re-incorporated into synaptic
vesicles for subsequent release.
Glial metabolism supports neurotransmission
Since early studies of brain energy metabolism, it has been
postulated that metabolic pathways leading to the production
of energy are under direct control of cerebral activity (van
den Berg et al. 1969). Aiming at elucidating how glucose
metabolism is related to both glutamatergic and GABAergic
synaptic transmission, we further compared the present
results with previous reports in rodents and humans that
considered all metabolic ﬂuxes as independent parameters
(Gruetter et al. 2001; Choi et al. 2002; Oz et al. 2004;
Duarte et al. 2011). In general, the present results are in line
with previous studies in either rodents or humans (Fig. 5b).
Interestingly, in addition to glucose oxidation (Sibson et al.
1998), glial pyruvate carboxylation was related to the total
neuron-glia neurotransmitter cycling (Fig. 5b). In fact, the
activity-induced increase in glial anaplerosis through VPC is
(a) (b)
Fig. 5 Comparison of metabolic ﬂuxes with those obtained from two-
compartment models. (a) Shows ﬂuxes obtained by ﬁtting models of
brain metabolism with three (ﬁlled bars) and two (open bars) compart-
ments to the present data. The two-compartment model was adapted
from Duarte et al. (2011) to include Vex
g. (b) Shows the relation of
estimated ﬂuxes of total glucose oxidation, neuronal and glial TCA
cycles and pyruvate carboxylation to glutamate/GABA-glutamine cycle,
that is, total VNT, across several studies using similar methodology in
the rat or human brain: (i) rat brain under pentobarbital-induced
isoelectricity (Choi et al. 2002), (ii) rat brain under light anaesthesia
(Duarte et al. 2011), (iii) human cortex (Gruetter et al. 2001), (iv) current
study, (v) awake rat brain (Oz et al. 2004). Metabolic ﬂuxes are shown
in lmol/g/min with associated SD. For linear regression, data sets (iv)
and (iii) were excluded in VTCA
n and VTCA
g, respectively.
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consistent with increased inﬂux of bicarbonate into astrocytes
upon neuronal release of K+ (Chesler 1990; Brookes and
Turner 1994) that may stimulate pyruvate carboxylation
(Gamberino et al. 1997) along with modulation of glycol-
ysis, glycogenolysis and lactate production (Choi et al.
2012). An intrinsic coupling between VPC, VGS and Vefﬂux
was deﬁned in the mathematical model, which ﬁnds support
in the fact that increased brain activity leads to ammonia
accumulation that likely requires detoxiﬁcation through
synthesis of glutamine that diffuses to the blood stream
(suggested by Merle and Franconi 2012).
The total ﬂux through pyruvate dehydrogenase in glia,
depicted by VTCA
g, also increased with VNT in the rat
brain. Because oxaloacetate produced from both pyruvate
carboxylation and GABA oxidation require equivalent
amount of acetyl-CoA for condensation, VTCA
g was
deﬁned as Vg + VPC + Vshunt
g (see Appendix), with Vg
(that was 66  8% of VTCAg) denoting the ﬂux through
glial pyruvate dehydrogenase corresponding to the com-
plete oxidation of pyruvate (Gruetter et al. 2001). Inter-
estingly, we did not observe a signiﬁcant modiﬁcation of
Vg with VNT (not shown), suggesting that pyruvate
carboxylation and GABA oxidation are the main drive
for the relation between glial VTCA and VNT, and that a
large fraction of glial energy production is probably
dedicated to non-signalling processes. In line with this,
energy consumption for tasks unrelated to neurotransmis-
sion could account for up to ~ 50% of total energy
expenditure in the whole rat brain (discussed in Howarth
et al. 2012).
The relationship between the rates of glutamatergic
neurotransmitter cycling and glucose oxidation in neurons
is well established in the literature (e.g. Hyder et al. 2013).
In agreement, oxidative metabolism in neurons was related
with VNT only for glutamatergic neurons, probably because
GABA re-uptake is less energy demanding and GABAergic
neurons receive substantial amount of glutamine synthesized
de novo by astrocytes (discussed above). Increase of glial
VTCA with VNT seemed to be species speciﬁc, being apparent
that the data set from the human brain is not in line with
those from rats.
Subcellular compartmentation of glial glutamine
In this study, we found that, when approaching isotopic
steady-state, glutamine enrichment in C4 was similar to that
in C2. This implies that glial dilution occurs and, therefore,
Vdil was introduced to represent the utilization of glial-
speciﬁc substrates that enter brain metabolism at the level
of acetyl-CoA (see Duarte et al. 2011 and references
therein). In addition, even when steady state of 13C
enrichment was reached for the mainly neuronal glutamate,
GABA and aspartate, a signiﬁcant and continuous increase
in glutamine enrichment occurs (Fig. 4a) in the presence of
a nearly constant total glutamine concentration, as measured
in vivo using 1H NMR spectroscopy under identical
experimental conditions (Duarte et al. 2009; Duarte and
Gruetter 2012). While pyruvate carboxylation could explain
this effect in glutamine C3 and C2, the C4 only receives
label from acetyl-CoA and thus should reach the steady-
state enrichment together with the remaining amino acids.
This continuous increase in brain glutamine enrichment
upon 13C-enriched glucose administration was also
observed in previous studies using dynamic 13C NMR
spectroscopy in vivo in both rodents (Duarte et al. 2011)
and humans (Shen et al. 1999).
Brain 13C-enriched glutamine was found higher than total
concentration of glutamine measured by 1H NMR spectros-
copy in vivo. This suggests that a fraction of brain glutamine
is not visible in the 1H NMR spectrum in vivo. In brain
extracts, levels of glutamine relative to glutamate were
similar to those measured in vivo (data not shown),
suggesting that this putative glutamine pool with low NMR
visibility (as suggested by Hancu and Port 2011) may be
associated with macromolecules that precipitate upon per-
chloric acid extraction. The eventual existence of glutamine
pools with different physical properties impelled us to test
an alternative model with a fourth glutamine pool of the size
of the non-visible glutamine, that is, difference between
5.3  0.4 lmol/g and glutamine concentration measured by
1H NMR spectroscopy. This pool was assumed to be in
direct exchange with glial glutamine indicated by Vex
g (see
Fig. 1).
The inclusion of a fourth glutamine pool in exchange with
one of the other three (the glial pool) resulted in an
approximation of the model curves to the measured data,
namely glutamine carbons. This pool was found to be
associated with a slow turnover and thus characterized by a
nearly continuous increase in 13C enrichment over the whole
analysed time course. Astrocyte morphology is compatible
with the existence of different functional domains and
evidence from in vitro studies in cultured astrocytes using
13C-labelled compounds may help unveil the existence of
multiple glial glutamine pools: in addition to mitochondrial
heterogeneity and glutamine synthesis from multiple TCA
cycles (Sonnewald et al. 1998; Waagepetersen et al. 2006),
intracellular and released glutamine displayed distinct label-
ling patters from metabolism of 13C-enriched glucose and
lactate (Waagepetersen et al. 2001). Together with our
results, these observations support the existence of a glial
glutamine pool with slow turnover that is not released to
neurons but could be used for protein synthesis or eventually
metabolized for energy production (discussed in McKenna
2007). In alternative, it is possible that metabolic heteroge-
neity occurs within the astrocytic syncytium or that multiple
glial compartments are present in the volume of interest
encompassing distinct brain areas. This scenario is however
difﬁcult to model because of the large number of parameters
to be estimated from the observed 13C enrichment curves.
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Mitochondrial membrane transport
Labelling of brain glutamate from 13C-enriched oxidative
substrates requires transfer of the label from the mitochon-
drial TCA cycle intermediate 2-oxoglutarate to cytosolic
glutamate, mainly via the 2-oxoglutarate-malate and gluta-
mate-aspartate carriers in the mitochondrial membrane,
which also sustains the transfer of reducing equivalents from
cytosol to mitochondria. In the compartments where the
GABA shunt occurs, that is, glia and GABAergic neurons, a
substantial part of 2-oxoglutarate transamination to glutamate
occurred with GABA (Vshunt), yielding SSA that is further
metabolized by the TCA cycle. Mitochondrial transport of
13C label in glia, that is, VX
g + VPC + Vshunt
g that includes
GABA transamination and net glutamate synthesis, was
much lower than the neuronal counterpart, which is in
agreement with the ﬁnding that carriers exchanging aspartate
and glutamate in the malate-aspartate shuttle are predomi-
nantly expressed in neurons rather than astrocytes (Ramos
et al. 2003; Berkich et al. 2007; Pardo et al. 2011). In
contrast, Li et al. recently found comparable amounts of
Aralar protein, the main mitochondrial carrier for aspartate/
glutamate in the brain, in freshly isolated neurons and
astrocytes (Li et al. 2012), suggesting that the transference of
reducing equivalents across the mitochondrial membrane is
not a limiting step for adaptation to altered metabolic or
energetic demand in astrocytes.
Although the rate of label transfer from 2-oxoglutarate to
glutamate is frequently thought to occur at a more rapid
rate than that of TCA cycle intermediate oxidation (e.g.
Mason et al. 1995; Sibson et al. 1998; Yang et al. 2009),
metabolic modelling of 13C NMR data from humans
(Gruetter et al. 2001) and rats (Choi et al. 2002; Oz et al.
2004; Duarte et al. 2011) with independent ﬂux estimation
found mitochondrial exchange ﬂuxes on the order of
the TCA cycle rate, as observed in this study. The present
data were only consistent with mitochondrial exchange
ﬂuxes in the same order of the respective TCA cycle rates
and the constraint of VX to be 10 times greater than VTCA
in each compartment lead to large ﬁt residuals (not
shown). This conclusion is further strengthened by the
ﬁnding that under near physiological conditions the rate of
2-oxoglutarate synthesis in brain mitochondria was similar
to that of a-ketoglutarate/glutamate efﬂux (Berkich et al.
2005). Furthermore, 2-oxoglutarate but not glutamate was
detected in the rat brain by 13C NMR spectroscopy upon
infusion of hyperpolarized acetate (Mishkovsky et al.
2012).
Conclusion
We conclude that GABAergic neurons consume a substantial
fraction of glucose and that glutamine of glial origin is an
important precursor for GABA synthesis in the rat brain
in vivo. This is in line with the metabolic cooperation
between astrocytes and neurons for maintenance of not only
excitatory but also inhibitory neurotransmission. Further-
more, subcellular metabolic compartmentation, namely in
astrocytes, can improve description of the experimental data
with mathematical models of brain metabolism.
Acknowledgements
This study was supported by Swiss National Science Foundation
(grant 131087) and by Centre d’Imagerie BioMédicale (CIBM) of
the UNIL, UNIGE, HUG, CHUV, EPFL and the Leenaards and
Jeantet Foundations. The authors are grateful to Patricia M. Nunes
(Radboud University Nijmegen Medical Centre, Nijmegen) and Dr.
Bernard Lanz (LIFMET) for fruitful discussions and to Jessica A.M.
Bastiaansen (LIFMET) for help with preparation of ﬁgures. The
authors declare no conﬂicts of interest.
Supporting information
Additional supporting information may be found in the online
version of this article at the publisher’s web-site.
Appendix S1. Three-compartment model of [1,6-13C]glucose
metabolism in the brain.
References
Bak L. K., Schousboe A. and Waagepetersen H. S. (2006) The
glutamate/GABA-glutamine cycle: aspects of transport,
neurotransmitter homeostasis and ammonia transfer. J.
Neurochem. 98, 641–653.
van den Berg C. J., Krzalic L., Mela P. and Waelsch H. (1969)
Compartmentation of glutamate metabolism in brain. Evidence for
the existence of two different tricarboxylic acid cycles in brain.
Biochem. J. 113, 281–290.
Berkich D. A., Xu Y., LaNoue K. F., Gruetter R. and Hutson S. M.
(2005) Evaluation of brain mitochondrial glutamate and alpha-
ketoglutarate transport under physiologic conditions. J. Neurosci.
Res. 79, 106–113.
Berkich D. A., Ola M. S., Cole J., Sweatt A. J., Hutson S. M. and
LaNoue K. F. (2007) Mitochondrial transport proteins of the brain.
J. Neurosci. Res. 85, 3367–3377.
Brookes N. and Turner R. J. (1994) K+-induced alkalinization in mouse
cerebral astrocytes mediated by reversal of electrogenic Na+-
HCO3
- cotransport. Am. J. Physiol. 267, C1633–C1640.
Calvetti D. and Somersalo E. (2012) Ménage a trois: the role of
neurotransmitters in the energy metabolism of astrocytes,
glutamatergic, and GABAergic neurons. J. Cereb. Blood Flow
Metab. 32, 1472–1483.
Chatton J. Y., Pellerin L. and Magistretti P. J. (2003) GABA uptake into
astrocytes is not associated with signiﬁcant metabolic cost:
implications for brain imaging of inhibitory transmission. Proc.
Natl Acad. Sci. USA 100, 12456–12461.
Chesler M. (1990) The regulation and modulation of pH in the nervous
system. Prog. Neurobiol. 34, 401–427.
Choi I. Y. and Gruetter R. (2003) In vivo 13C NMR assessment of brain
glycogen concentration and turnover in the awake rat. Neurochem.
Int. 43, 317–322.
Choi I.-Y. and Shen J. (2012) In vivo GABA metabolism, in Neural
Metabolism In Vivo (Choi I.-Y. and Gruetter R., eds), pp. 1095–
1116. Springer, New York.
© 2013 International Society for Neurochemistry, J. Neurochem. (2013) 126, 579--590
588 J. M. N. Duarte and R. Gruetter
Choi I. Y., Lei H. and Gruetter R. (2002) Effect of deep pentobarbital
anesthesia on neurotransmitter metabolism in vivo: on the
correlation of total glucose consumption with glutamatergic
action. J. Cereb. Blood Flow Metab. 22, 1343–1351.
Choi H. B., Gordon G. R., Zhou N. et al. (2012) Metabolic
communication between astrocytes and neurons via bicarbonate-
responsive soluble adenylyl cyclase. Neuron 75, 1094–1104.
Conti F., Minelli A. and Melone M. (2004) GABA transporters in the
mammalian cerebral cortex: localization, development and
pathological implications. Brain Res. Brain Res. Rev. 45, 196–212.
DeFelipe J. and Fari~nas I. (1992) The pyramidal neuron of the cerebral
cortex: morphological and chemical characteristics of the synaptic
inputs. Prog. Neurobiol. 39, 563–607.
Duarte J. M. N. and Gruetter R. (2012) Characterization of cerebral
glucose dynamics in vivo with a four-state conformational model of
transport at the blood-brain-barrier. J. Neurochem. 121, 396–406.
Duarte J. M. N., Cunha R. A. and Carvalho R. A. (2007) Different
metabolism of glutamatergic and GABAergic compartments in
superfused hippocampal slices characterized by nuclear magnetic
resonance spectroscopy. Neuroscience 144, 1305–1313.
Duarte J. M. N., Carvalho R. A., Cunha R. A. and Gruetter R. (2009)
Caffeine consumption attenuates neurochemical modiﬁcations in
the hippocampus of streptozotocin-induced diabetic rats. J.
Neurochem. 111, 368–379.
Duarte J. M. N., Lanz B. and Gruetter R. (2011) Compartmentalized
cerebral metabolism of [1,6-13C]glucose Determined by in vivo 13C
NMR spectroscopy at 14.1 T. Front. Neuroenergetics 3, 3.
van Eijsden P., Behar K. L., Mason G. F., Braun K. P. and de Graaf R.
A. (2010) In vivo neurochemical proﬁling of rat brain by 1H-[13C]
NMR spectroscopy: cerebral energetics and glutamatergic/
GABAergic neurotransmission. J. Neurochem. 112, 24–33.
Gadea A. and Lopez-Colomé A. M. (2001) Glial transporters for
glutamate, glycine, and GABA: II. GABA transporters. J.
Neurosci. Res. 63, 461–468.
Gamberino W. C., Berkich D. A., Lynch C. J., Xu B. and LaNoue K. F.
(1997) Role of pyruvate carboxylase in facilitation of synthesis of
glutamate and glutamine in cultured astrocytes. J. Neurochem. 69,
2312–2325.
Gruetter R. (1993) Automatic, localized in vivo adjustment of all ﬁrst-
and second-order shim coils. Magn. Reson. Med. 29, 804–811.
Gruetter R. (2002) In vivo 13C NMR studies of compartmentalized
cerebral carbohydrate metabolism. Neurochem. Int. 41, 143–154.
Gruetter R. and Tkac I. (2000) Field mapping without reference scan
using asymmetric echo-planar techniques. Magn. Reson. Med. 43,
319–323.
Gruetter R., Novotny E. J., Boulware S. D., Mason G. F., Rothman D. L.,
Shulman G. I., Prichard J. W. and Shulman R. G. (1994) Localized
13C NMR spectroscopy in the human brain of amino acid labeling
from D-[1-13C]glucose. J. Neurochem. 63, 1377–1385.
Gruetter R., Seaquist E. R. and Ugurbil K. (2001) A mathematical model
of compartmentalized neurotransmitter metabolism in the human
brain. Am. J. Physiol. Endocrinol. Metab. 281, E100–E112.
Hancu I. and Port J. (2011) The case of the missing glutamine. NMR
Biomed. 24, 529–535.
Henry P. G., Tkac I. and Gruetter R. (2003a) 1H-localized broadband 13C
NMR spectroscopy of the rat brain in vivo at 9.4 T. Magn. Reson.
Med. 50, 684–692.
Henry P. G., Oz G., Provencher S. and Gruetter R. (2003b) Toward
dynamic isotopomer analysis in the rat brain in vivo: automatic
quantitation of 13C NMR spectra using LCModel. NMR Biomed.
16, 400–412.
Howarth C., Gleeson P. and Attwell D. (2012) Updated energy budgets
for neural computation in the neocortex and cerebellum. J. Cereb.
Blood Flow Metab. 32, 1222–1232.
Hyder F., Fulbright R. K., Shulman R. G. and Rothman D. L. (2013)
Glutamatergic function in the resting awake human brain is
supported by uniformly high oxidative energy. J. Cereb. Blood
Flow Metab. 33, 339–347.
Li B., Hertz L. and Peng L. (2012) Aralar mRNA and protein levels in
neurons and astrocytes freshly isolated from young and adult
mouse brain and in maturing cultured astrocytes. Neurochem. Int.
61, 1325–1332.
Malloy C. R., Sherry A. D. and Jeffrey F. M. (1987) Carbon ﬂux through
citric acid cycle pathways in perfused heart by 13C NMR
spectroscopy. FEBS Lett. 212, 58–62.
Mason G. F., Gruetter R., Rothman D. L., Behar K. L., Shulman R. G.
and Novotny E. J. (1995) Simultaneous determination of the rates
of the TCA cycle, glucose utilization, alpha-ketoglutarate/
glutamate exchange, and glutamine synthesis in human brain by
NMR. J. Cereb. Blood Flow Metab. 15, 12–25.
McKenna M. C. (2007) The glutamate-glutamine cycle is not
stoichiometric: fates of glutamate in brain. J. Neurosci. Res. 85,
3347–3358.
Merle M. and Franconi J.-M. (2012) Brain metabolic
compartmentalization, metabolism modeling, and cerebral activity-
metabolism relationship, in Neural Metabolism In Vivo (Choi I.-Y.
and Gruetter R., eds), pp. 947–992. Springer, New York.
Mishkovsky M., Comment A. and Gruetter R. (2012) In vivo detection
of brain Krebs cycle intermediate by hyperpolarized magnetic
resonance. J. Cereb. Blood Flow Metab. 32, 2108–2113.
Mlynarik V., Gambarota G., Frenkel H. and Gruetter R. (2006)
Localized short-echo-time proton MR spectroscopy with full
signal-intensity acquisition. Magn. Reson. Med. 56, 965–970.
Oz G., Berkich D. A., Henry P. G., Xu Y., LaNoue K., Hutson S. M. and
Gruetter R. (2004) Neuroglial metabolism in the awake rat brain:
CO2 ﬁxation increases with brain activity. J. Neurosci. 24, 11273–
11279.
Pardo B., Rodrigues T. B., Contreras L., Garzon M., Llorente-Folch I.,
Kobayashi K., Saheki T., Cerdan S. and Satrustegui J. (2011) Brain
glutamine synthesis requires neuronal-born aspartate as amino
donor for glial glutamate formation. J. Cereb. Blood Flow Metab.
31, 90–101.
Patel A. B., de Graaf R. A., Mason G. F., Rothman D. L., Shulman R. G.
and Behar K. L. (2005) The contribution of GABA to glutamate/
glutamine cycling and energy metabolism in the rat cortex in vivo.
Proc. Natl Acad. Sci. USA 102, 5588–5593.
Pfeuffer J., Tkac I., Choi I. Y., Merkle H., Ugurbil K., Garwood M. and
Gruetter R. (1999) Localized in vivo 1H NMR detection of
neurotransmitter labeling in rat brain during infusion of [1-13C] D-
glucose. Magn. Reson. Med. 41, 1077–1083.
Ramos M., del Arco A., Pardo B. et al. (2003) Developmental changes
in the Ca2+-regulated mitochondrial aspartate-glutamate carrier
aralar1 in brain and prominent expression in the spinal cord. Dev.
Brain Res. 143, 33–46.
Sahara S., Yanagawa Y., O’Leary D. D. and Stevens C. F. (2012) The
fraction of cortical GABAergic neurons is constant from near the start
of cortical neurogenesis to adulthood. J. Neurosci. 32, 4755–4761.
Schousboe A. and Waagepetersen H. S. (2003) Role of astrocytes in
homeostasis of glutamate and GABA during physiological and
pathophysiological conditions. Adv. Mol. Cell Biol. 31, 461–474.
Schousboe A. and Waagepetersen H. S. (2007) GABA: homeostatic and
pharmacological aspects. Prog. Brain Res. 160, 9–19.
Schousboe A., Westergaard N., Sonnewald U., Petersen S. B., Yu A. C.
and Hertz L. (1992) Regulatory role of astrocytes for neuronal
biosynthesis and homeostasis of glutamate and GABA. Prog.
Brain Res. 94, 199–211.
Shen J., Petersen K. F., Behar K. L., Brown P., Nixon T. W., Mason G.
F., Petroff O. A., Shulman G. I., Shulman R. G. and Rothman D. L.
© 2013 International Society for Neurochemistry, J. Neurochem. (2013) 126, 579--590
Glutamatergic and GABAergic energy metabolism 589
(1999) Determination of the rate of the glutamate/glutamine cycle
in the human brain by in vivo 13C NMR. Proc. Natl Acad. Sci. USA
96, 8235–8240.
Shestov A. A., Valette J., Ugurbil K. and Henry P. G. (2007) On the
reliability of 13C metabolic modeling with two-compartment
neuronal-glial models. J. Neurosci. Res. 85, 3294–3303.
Sibson N. R., Dhankhar A., Mason G. F., Rothman D. L., Behar K. L.
and Shulman R. G. (1998) Stoichiometric coupling of brain
glucose metabolism and glutamatergic neuronal activity. Proc. Natl
Acad. Sci. USA 95, 316–321.
Sonnewald U., Hertz L. and Schousboe A. (1998) Mitochondrial
heterogeneity in the brain at the cellular level. J. Cereb. Blood
Flow Metab. 18, 231–237.
Tkac I., Rao R., Georgieff M. K. and Gruetter R. (2003) Developmental
and regional changes in the neurochemical proﬁle of the rat brain
determined by in vivo 1H NMR spectroscopy. Magn. Reson. Med.
50, 24–32.
Waagepetersen H. S., Sonnewald U. and Schousboe A. (1999) The
GABA paradox: multiple roles as metabolite, neurotransmitter, and
neurodifferentiative agent. J. Neurochem. 73, 1335–1342.
Waagepetersen H. S., Sonnewald U., Larsson O. M. and Schousboe A.
(2001) Multiple compartments with different metabolic character-
istics are involved in biosynthesis of intracellular and released
glutamine and citrate in astrocytes. Glia 35, 246–252.
Waagepetersen H. S., Hansen G. H., Fenger K., Lindsay J. G., Gibson
G. and Schousboe A. (2006) Cellular mitochondrial hetero-
geneity in cultured astrocytes as demonstrated by immuno-
gold labeling of alpha-ketoglutarate dehydrogenase. Glia 53,
225–231.
Westergaard N., Sonnewald U., Petersen S. B. and Schousboe A. (1995)
Glutamate and glutamine metabolism in cultured GABAergic
neurons studied by 13C NMR spectroscopy may indicate
compartmentation and mitochondrial heterogeneity. Neurosci.
Lett. 185, 24–28.
Xin L., Mlynarik V., Lanz B., Frenkel H. and Gruetter R. (2010) 1H-
[13C] NMR spectroscopy of the rat brain during infusion of [2-13C]
acetate at 14.1 T. Magn. Reson. Med. 64, 334–340.
Yang J., Li C. Q. and Shen J. (2005) In vivo detection of cortical GABA
turnover from intravenously infused [1-13C]D-glucose. Magn.
Reson. Med. 53, 1258–1267.
Yang J., Xu S. and Shen J. (2009) Fast isotopic exchange between
mitochondria and cytosol in brain revealed by relayed 13C
magnetization transfer spectroscopy. J. Cereb. Blood Flow
Metab. 29, 661–669.
© 2013 International Society for Neurochemistry, J. Neurochem. (2013) 126, 579--590
590 J. M. N. Duarte and R. Gruetter
